D-Nome Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
D-Nome General Information
Description
Developer of a molecular reagent technology designed for simple and affordable genomics-based diagnostics. The company's technology leverages proprietary, innovative reagent technologies to offer advanced molecular biology techniques like reverse transcription-polymerase chain reaction (RT-PCR) and genome sequencing tools for early and accurate diagnosis in clinical diagnostics, enabling healthcare institutions to reduce operational costs.
Contact Information
Website
www.dnome.inCorporate Office
- 3rd Floor, AIC-CCMB, Uppal
- Hyderabad, Telangana 500007
- India
Corporate Office
- 3rd Floor, AIC-CCMB, Uppal
- Hyderabad, Telangana 500007
- India
D-Nome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 01-Feb-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Seed Round | 13-Oct-2022 | $1.5M | $1.56M | Completed | Generating Revenue | |
| 1. Seed Round | 28-Sep-2021 | $57.9K | $57.9K | Completed | Generating Revenue |
D-Nome Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Prefernce Shares | ||||||||
| Prefernce Shares | 1,000 | $0.123175 | $52.42 | $52.42 | 1x | $52.42 | 6.34% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
D-Nome Comparisons
Industry
Financing
Details
D-Nome Competitors (2)
One of D-Nome’s 2 competitors is Curetis, a Private Equity-Backed company based in Holzgerlingen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Curetis | Private Equity-Backed | Holzgerlingen, Germany | ||||
| Sherlock Biosciences | Formerly VC-backed | Watertown, MA |
D-Nome Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
D-Nome Patents
D-Nome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026022678-A1 | Method and device for isolating and enriching pathogenic nucleic acids from biological samples | Pending | 22-Jul-2024 | ||
| EP-4437124-A1 | Rapid method for room temperature reverse transcription loop-mediated isothermal amplification (rt-lamp) and reagent kit | Pending | 24-Nov-2021 | ||
| EP-4437124-A4 | Rapid method for room temperature reverse transcription loop-mediated isothermal amplification (rt-lamp) and reagent kit | Pending | 24-Nov-2021 | ||
| US-20250171864-A1 | Rapid method for room temperature reverse transcription loop-mediated isothermal amplification (rt-lamp) and reagent kit | Pending | 24-Nov-2021 | ||
| WO-2023095018-A1 | Rapid method for room temperature reverse transcription loop-mediated isothermal amplification (rt-lamp) and reagent kit | Inactive | 24-Nov-2021 | C12Q1/701 |
D-Nome Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
D-Nome Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ASPIRE-BioNEST | Accelerator/Incubator | |||
| 3iPartners | Venture Capital | Minority | ||
| 8X Ventures | Venture Capital | Minority | ||
| Ankur Capital | Venture Capital | Minority | ||
| Campus Fund (India) | Venture Capital | Minority |
D-Nome FAQs
-
When was D-Nome founded?
D-Nome was founded in 2021.
-
Where is D-Nome headquartered?
D-Nome is headquartered in Hyderabad, India.
-
What is the size of D-Nome?
D-Nome has 10 total employees.
-
What industry is D-Nome in?
D-Nome’s primary industry is Diagnostic Equipment.
-
Is D-Nome a private or public company?
D-Nome is a Private company.
-
What is D-Nome’s current revenue?
The current revenue for D-Nome is .
-
How much funding has D-Nome raised over time?
D-Nome has raised $1.56M.
-
Who are D-Nome’s investors?
ASPIRE-BioNEST, 3iPartners, 8X Ventures, Ankur Capital, and Campus Fund (India) are 5 of 9 investors who have invested in D-Nome.
-
Who are D-Nome’s competitors?
Curetis and Sherlock Biosciences are competitors of D-Nome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
